Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
202.4 USD | +6.54% | 0.00% | +22.03% |
02:10pm | Oppenheimer Adjusts Price Target on JPMorgan to $215 From $217 | MT |
01:29pm | Major Banks to Pay $46 Million to Settle Litigation Over Alleged Interest Rate Swaps Collusion | MT |
Strengths
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
Ratings chart - Surperformance
Sector: Banks
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+22.03% | 572B | - | ||
+17.79% | 307B | C+ | ||
+21.47% | 262B | C+ | ||
+24.09% | 186B | B- | ||
+29.19% | 174B | B- | ||
+7.62% | 160B | C+ | ||
-1.49% | 155B | B- | ||
+8.86% | 150B | B- | ||
+13.94% | 140B | C+ | ||
+42.72% | 121B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- JPM Stock
- JPM_KZ Stock
- Ratings JPMorgan Chase & Co.